Global Market Study on Circadian Rhythm Sleep Treatment: Extensive research in therapy devices along with adoption of drugs to drive the growth
Circadian Rhythm Sleep Treatment Market Analysis 2022-2026
A recent market study published by Persistence Market Research (PMR) on the Circadian Rhythm Sleep Treatment Market including global industry analysis for 2013-2021 & opportunity assessment for 2022-2026, delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the market, growth prospects are obtained with utmost precision.
Circadian Rhythm Sleep Treatment Market: Segmentation
The global Circadian Rhythm Sleep Treatment Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
Disorder
Delayed Sleep Phase Syndrome
Advanced Sleep Phase Syndrome
Non–24-h sleep-wake syndrome
Irregular Sleep-Wake Disorder
Shift Work Disorder
Jet Lag
Treatment Type
Therapeutic Devices
Drugs
Chronotherapy
Distribution Channel
Institutional Sales
Retail Sales
Region
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa (MEA)
Key Questions Answered in Report
The research study offers inclusive insights about the growth of the market in the most comprehensive manner. Key insights offered in the report answer some of the most salient questions that assist stakeholders in gauging all the emerging possibilities.
What are the key trends that are constantly shaping market growth?
Which are the prominent regions that offer plentiful opportunities for players in the market?
How has the outbreak of COVID-19 affected the market and what would the trend be like during the forecast period?
What are the differential strategies adopted by key players to hold a significant share in the Circadian Rhythm Sleep Treatment industry?
Research Methodology
A unique and promising research methodology forms the base of the market report for the forecast period. This report has been prepared after comprehensive analysis of market events, and riveting insights have been compiled meticulously.
The research methodology is a two-step process comprising primary and secondary research. Key stakeholders, including suppliers, service providers, and experts of several designations, including executive vice presidents, directors, technical advisors, GM marketing professionals, and sales professionals have been interviewed. Secondary sources referred to obtain information include investor presentations of manufacturers, World Bank, IMF, and other credible sources.
The research report includes a competitive landscape that provides a dashboard view of the key competitors operating in the market. Some of the market players included in this section are Vanda Pharmaceuticals, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., The Sunbox Company, Verilux, Inc., Carex Health, Northern Light Technologies, Koninklijke Philips N.V., Amjo Corp, and Lucimed SA.
- 1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Demand Side Trends
- 1.3. Supply Side Trends
- 1.4. Disorder Roadmap Analysis
- 1.5. Analysis and Recommendations
- 2. Market Introduction
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
- 3. Global Circadian Rhythm Sleep Treatment Market Key Trends
- 3.1. Key Trends Impacting the Market
- 3.2. Product Innovation Trends
- 3.3. Innovations & New Launches
- 3.4. Disease Overview and Epidemiology (Prevalence Data), by Region
- 4. Global Circadian Rhythm Sleep Treatment Market Key Success Factors
- 4.1. Product Adoption / Awareness Analysis
- 4.2. Product Features Vs. Disorder Matrix
- 5. Global Circadian Rhythm Sleep Treatment Market – Pricing Analysis
- 5.1. Regional Pricing Analysis
- 5.2. Pricing Break-Up
- 5.2.1. Manufacturer Level Pricing
- 5.2.2. Distributor Level Pricing
- 5.3. Global Average Pricing Analysis Benchmark
- 6. Global Circadian Rhythm Sleep Treatment Market Demand Analysis 2013-2021 and Forecast, 2022 - 2026
- 6.1. Historical Market Value (US$ Mn) Analysis, 2013-2021
- 6.2. Current and Future Market Value (US$ Mn) Projections, 2022 - 2026
- 6.3. Y-o-Y Growth Trend Analysis
- 7. Global Circadian Rhythm Sleep Treatment Market Context
- 7.1. Key Regulations
- 7.2. Macro-Economic Factors
- 7.3. Forecast Factors – Relevance & Impact
- 7.4. Market Dynamics
- 7.4.1. Drivers
- 7.4.2. Restraints
- 7.4.3. Opportunity Analysis
- 8. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Treatment Type
- 8.1. Introduction/Key Finding
- 8.1.1. Market Size (US$ Mn) and Volume Share Analysis By Treatment Type
- 8.1.2. Y-o-Y Growth Analysis By Treatment Type
- 8.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Treatment Type, 2013-2021
- 8.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Treatment Type, 2022 - 2026
- 8.3.1. Devices
- 8.3.1.1. Therapeutic Devices
- 8.3.1.1.1. Light Box
- 8.3.1.1.2. Desk Lamps
- 8.3.1.1.3. Light Visor
- 8.3.1.1.4. Dawn Simulator
- 8.3.1.2. Diagnostic Devices
- 8.3.1.2.1. Actigraphy Sensors
- 8.3.1.2.1.1. Wrist and Hand band Actigraphy Devices
- 8.3.1.2.1.2. Wearable Actigraphy Devices
- 8.3.1.2.2. Polysomnography Devices
- 8.3.1.2.2.1. Fixed Polysomnography Devices
- 8.3.1.2.2.2. Portable Polysomnography Devices
- 8.3.2. Drugs
- 8.3.2.1. Benzodiazepines
- 8.3.2.2. Nonbenzodiazepine hypnotics
- 8.3.2.3. Orexin receptor antagonists
- 8.3.2.4. Melatonin receptor agonist
- 8.3.3. Chronotherapy
- 8.4. Market Attractiveness Analysis By Treatment Type
- 9. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Disorder
- 9.1. Introduction/Key Finding
- 9.1.1. Market Size (US$ Mn) Analysis By Disorder
- 9.1.2. Y-o-Y Growth Analysis By Disorder
- 9.2. Historical Market Size (US$ Mn) Analysis By Disorder , 2013-2021
- 9.3. Market Size (US$ Mn) Forecast By Disorder , 2022 - 2026
- 9.3.1. Delayed Sleep Phase Syndrome (DSPS)
- 9.3.2. Advanced Sleep Phase Syndrome (ASPS)
- 9.3.3. Non–24-h Sleep-Wake Syndrome
- 9.3.4. Irregular Sleep-Wake Disorder (ISWD)
- 9.3.5. Shift Work Disorder
- 9.3.6. Jet Lag
- 9.4. Market Attractiveness Analysis By Disorder
- 10. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Distribution Channel
- 10.1. Introduction/Key Finding
- 10.1.1. Market Size (US$ Mn) Analysis By Distribution Channel
- 10.1.2. Y-o-Y Growth Analysis By Distribution Channel
- 10.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013-2021
- 10.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2022 - 2026
- 10.3.1. Institutional Sales
- 10.3.1.1. Home Care Settings
- 10.3.1.2. Wellness Centers & Spa
- 10.3.1.3. Sleep Testing Centers
- 10.3.1.4. Specialty Clinics
- 10.3.1.5. Hospitals
- 10.3.2. Retail Sales
- 10.3.2.1. Retail Pharmacies
- 10.3.2.2. Drug Stores
- 10.3.2.3. Online Sales
- 10.4. Market Attractiveness Analysis By Distribution Channel
- 11. Global Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026, By Region
- 11.1. Introduction/Key Finding
- 11.1.1. Market Size (US$ Mn) and Volume Share Analysis By Region
- 11.1.2. Y-o-Y Growth Analysis By Region
- 11.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Region, 2013-2021
- 11.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Region, 2022 - 2026
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. South Asia
- 11.3.5. East Asia
- 11.3.6. Oceania
- 11.3.7. Middle East and Africa
- 11.4. Market Attractiveness Analysis By Region
- 12. North America Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 12.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 12.3.1. By Country
- 12.3.1.1. U.S.
- 12.3.1.2. Canada
- 12.3.2. By Treatment Type
- 12.3.3. By Disorder
- 12.3.4. By Distribution Channel
- 12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Treatment Type
- 12.4.3. By Disorder
- 12.4.4. By Distribution Channel
- 12.5. Drivers and Restraints: Impact Analysis
- 12.6. Key Market Participants – Intensity Mapping
- 13. Latin America Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
- 13.1. Introduction
- 13.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 13.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 13.3.1. By Country
- 13.3.1.1. Brazil
- 13.3.1.2. Mexico
- 13.3.1.3. Argentina
- 13.3.1.4. Rest of Latin America
- 13.3.2. By Treatment Type
- 13.3.3. By Disorder
- 13.3.4. By Distribution Channel
- 13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Treatment Type
- 13.4.3. By Disorder
- 13.4.4. By Distribution Channel
- 13.5. Drivers and Restraints: Impact Analysis
- 13.6. Key Market Participants – Intensity Mapping
- 14. Europe Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
- 14.1. Introduction
- 14.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 14.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 14.3.1. By Country
- 14.3.1.1. U.K.
- 14.3.1.2. Germany
- 14.3.1.3. France
- 14.3.1.4. Italy
- 14.3.1.5. Spain
- 14.3.1.6. BENELUX
- 14.3.1.7. Nordic
- 14.3.1.8. Poland
- 14.3.1.9. Rest of Europe
- 14.3.2. By Treatment Type
- 14.3.3. By Disorder
- 14.3.4. By Distribution Channel
- 14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Treatment Type
- 14.4.3. By Disorder
- 14.4.4. By Distribution Channel
- 14.5. Drivers and Restraints: Impact Analysis
- 14.6. Key Market Participants – Intensity Mapping
- 15. East-Asia Circadian Rhythm Sleep Treatment Market Analysis 2013-2021 and Forecast 2022 - 2026
- 15.1. Introduction
- 15.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 15.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 15.3.1. By Country
- 15.3.1.1. China
- 15.3.1.2. Japan
- 15.3.1.3. South Korea
- 15.3.1.4. Rest of East Asia
- 15.3.2. By Treatment Type
- 15.3.3. By Disorder
- 15.3.4. By Distribution Channel
- 15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Treatment Type
- 15.4.3. By Disorder
- 15.4.4. By Distribution Channel
- 15.5. Drivers and Restraints: Impact Analysis
- 15.6. Key Market Participants – Intensity Mapping
- 16. South Asia Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
- 16.1. Introduction
- 16.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 16.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 16.3.1. By Country
- 16.3.1.1. India
- 16.3.1.2. Thailand
- 16.3.1.3. Malaysia
- 16.3.1.4. Indonesia
- 16.3.1.5. Philippines
- 16.3.1.6. Rest of South Asia
- 16.3.2. By Treatment Type
- 16.3.3. By Disorder
- 16.3.4. By Distribution Channel
- 16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Treatment Type
- 16.4.3. By Disorder
- 16.4.4. By Distribution Channel
- 16.5. Drivers and Restraints: Impact Analysis
- 16.6. Key Market Participants – Intensity Mapping
- 17. Oceania Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
- 17.1. Introduction
- 17.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 17.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 17.3.1. By Country
- 17.3.1.1. Australia
- 17.3.1.2. New Zealand
- 17.3.2. By Treatment Type
- 17.3.3. By Disorder
- 17.3.4. By Distribution Channel
- 17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Treatment Type
- 17.4.3. By Disorder
- 17.4.4. By Distribution Channel
- 17.5. Drivers and Restraints: Impact Analysis
- 17.6. Key Market Participants – Intensity Mapping
- 18. MEA Circadian Rhythm Sleep Treatment Market Analysis and Forecast 2013-2021 and Forecast 2022 - 2026
- 18.1. Introduction
- 18.2. Historical Market Size (US$ Mn) and Volume (US$ Mn) Analysis By Market Segments, 2013-2021
- 18.3. Market Size (US$ Mn) and Volume (US$ Mn) Forecast By Market Segments, 2022 - 2026
- 18.3.1. By Country
- 18.3.1.1. GCC Countries
- 18.3.1.2. Iran
- 18.3.1.3. Israel
- 18.3.1.4. Turkey
- 18.3.1.5. Rest of MEA
- 18.3.2. By Treatment Type
- 18.3.3. By Disorder
- 18.3.4. By Distribution Channel
- 18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Treatment Type
- 18.4.3. By Disorder
- 18.4.4. By Distribution Channel
- 18.5. Drivers and Restraints: Impact Analysis
- 18.6. Key Market Participants – Intensity Mapping
- 19. Competition Analysis
- 19.1. Competition Dashboard
- 19.2. Pricing Analysis, By Competition
- 19.3. Competition Benchmarking
- 19.4. Gross Margin Analysis, By Competition
- 19.5. Competition Developments
- 19.6. Competition Deep Dive
- 19.6.1. Vanda Pharmaceuticals Inc.
- 19.6.1.1. Overview
- 19.6.1.2. Product and Disorder Portfolio
- 19.6.1.3. Production Footprint
- 19.6.1.4. Sales Footprint
- 19.6.1.5. Strategy
- 19.6.1.5.1. Marketing Strategy
- 19.6.1.5.2. Product Strategy
- 19.6.1.5.3. Channel Strategy
- 19.6.2. Natus Medical Incorporated
- 19.6.2.1. Overview
- 19.6.2.2. Product and Disorder Portfolio
- 19.6.2.3. Production Footprint
- 19.6.2.4. Sales Footprint
- 19.6.2.5. Strategy
- 19.6.2.5.1. Marketing Strategy
- 19.6.2.5.2. Product Strategy
- 19.6.2.5.3. Channel Strategy
- 19.6.3. Compumedics Ltd.
- 19.6.3.1. Overview
- 19.6.3.2. Product and Disorder Portfolio
- 19.6.3.3. Production Footprint
- 19.6.3.4. Sales Footprint
- 19.6.3.5. Strategy
- 19.6.3.5.1. Marketing Strategy
- 19.6.3.5.2. Product Strategy
- 19.6.3.5.3. Channel Strategy
- 19.6.4. Teva Pharmaceutical Industries Ltd
- 19.6.4.1. Overview
- 19.6.4.2. Product and Disorder Portfolio
- 19.6.4.3. Production Footprint
- 19.6.4.4. Sales Footprint
- 19.6.4.5. Strategy
- 19.6.4.5.1. Marketing Strategy
- 19.6.4.5.2. Product Strategy
- 19.6.4.5.3. Channel Strategy
- 19.6.5. Takeda Pharmaceutical Company
- 19.6.5.1. Overview
- 19.6.5.2. Product and Disorder Portfolio
- 19.6.5.3. Production Footprint
- 19.6.5.4. Sales Footprint
- 19.6.5.5. Strategy
- 19.6.5.5.1. Marketing Strategy
- 19.6.5.5.2. Product Strategy
- 19.6.5.5.3. Channel Strategy
- 19.6.6. Koninklijke Philips N.V
- 19.6.6.1. Overview
- 19.6.6.2. Product and Disorder Portfolio
- 19.6.6.3. Production Footprint
- 19.6.6.4. Sales Footprint
- 19.6.6.5. Strategy
- 19.6.6.5.1. Marketing Strategy
- 19.6.6.5.2. Product Strategy
- 19.6.6.5.3. Channel Strategy
- 19.6.7. Mylan N.V
- 19.6.7.1. Overview
- 19.6.7.2. Product and Disorder Portfolio
- 19.6.7.3. Production Footprint
- 19.6.7.4. Sales Footprint
- 19.6.7.5. Strategy
- 19.6.7.5.1. Marketing Strategy
- 19.6.7.5.2. Product Strategy
- 19.6.7.5.3. Channel Strategy
- 19.6.8. Fitbit, Inc
- 19.6.8.1. Overview
- 19.6.8.2. Product and Disorder Portfolio
- 19.6.8.3. Production Footprint
- 19.6.8.4. Sales Footprint
- 19.6.8.5. Strategy
- 19.6.8.5.1. Marketing Strategy
- 19.6.8.5.2. Product Strategy
- 19.6.8.5.3. Channel Strategy
- 19.6.9. Garmin Ltd
- 19.6.9.1. Overview
- 19.6.9.2. Product and Disorder Portfolio
- 19.6.9.3. Production Footprint
- 19.6.9.4. Sales Footprint
- 19.6.9.5. Strategy
- 19.6.9.5.1. Marketing Strategy
- 19.6.9.5.2. Product Strategy
- 19.6.9.5.3. Channel Strategy
- 19.6.10. Lucimed S.A.
- 19.6.10.1. Overview
- 19.6.10.2. Product and Disorder Portfolio
- 19.6.10.3. Production Footprint
- 19.6.10.4. Sales Footprint
- 19.6.10.5. Strategy
- 19.6.10.5.1. Marketing Strategy
- 19.6.10.5.2. Product Strategy
- 19.6.10.5.3. Channel Strategy
- 19.6.11. RedMed Inc.
- 19.6.11.1. Overview
- 19.6.11.2. Product and Disorder Portfolio
- 19.6.11.3. Production Footprint
- 19.6.11.4. Sales Footprint
- 19.6.11.5. Strategy
- 19.6.11.5.1. Marketing Strategy
- 19.6.11.5.2. Product Strategy
- 19.6.11.5.3. Channel Strategy
- 19.6.12. Compass Health Brands (Carex Health)
- 19.6.12.1. Overview
- 19.6.12.2. Product and Disorder Portfolio
- 19.6.12.3. Production Footprint
- 19.6.12.4. Sales Footprint
- 19.6.12.5. Strategy
- 19.6.12.5.1. Marketing Strategy
- 19.6.12.5.2. Product Strategy
- 19.6.12.5.3. Channel Strategy
- 19.6.13. Beurer GmbH
- 19.6.13.1. Overview
- 19.6.13.2. Product and Disorder Portfolio
- 19.6.13.3. Production Footprint
- 19.6.13.4. Sales Footprint
- 19.6.13.5. Strategy
- 19.6.13.5.1. Marketing Strategy
- 19.6.13.5.2. Product Strategy
- 19.6.13.5.3. Channel Strategy
- 19.6.14. Samarit Medical AG
- 19.6.14.1. Overview
- 19.6.14.2. Product and Disorder Portfolio
- 19.6.14.3. Production Footprint
- 19.6.14.4. Sales Footprint
- 19.6.14.5. Strategy
- 19.6.14.5.1. Marketing Strategy
- 19.6.14.5.2. Product Strategy
- 19.6.14.5.3. Channel Strategy
- 19.6.15. Lanaform N.V.
- 19.6.15.1. Overview
- 19.6.15.2. Product and Disorder Portfolio
- 19.6.15.3. Production Footprint
- 19.6.15.4. Sales Footprint
- 19.6.15.5. Strategy
- 19.6.15.5.1. Marketing Strategy
- 19.6.15.5.2. Product Strategy
- 19.6.15.5.3. Channel Strategy
- 20. Assumptions and Acronyms Used
- 21. Research Methodology
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook